Article
Met endosomal signalling: in the right place, at the right time.
The international journal of biochemistry & cell biology - 1 Apr 2014
Barrow-McGee Rachel, Kermorgant Stéphanie
Abstract excerpt
Deregulated signalling of the Receptor Tyrosine Kinase (RTK), Met, and/or its ligand HGF have been associated with cancer formation and progression to metastasis, with Met/HGF often overexpressed or mutated. Thus, Met has become a major target for cancer therapy and its inhibition is currently being tested in the clinic. It has recently become evident that, instead of signalling at the plasma membrane only, Met...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
